---

Emphysema: From Basics to Clinical

---

1. Definition

• Robbins & Kumar Basic Pathology, p. 448
• Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 634

---

2. Anatomy Primer: The Acinus

• Respiratory bronchioles
• Alveolar ducts
• Alveolar sacs and alveoli

---

3. Classification / Types of Emphysema

(A) Centriacinar (Centrilobular) Emphysema

• Most common type - >95% of clinically significant cases
• Destruction of the central/proximal parts of the acinus (respiratory bronchioles), with sparing of distal alveoli
• Both emphysematous and normal airspaces coexist in the same lobule
• Distribution: Upper lobes, apical segments predominate
• Cause: Almost exclusively in cigarette smokers, often with concurrent chronic bronchitis
• The "classic" smoking-related emphysema

(B) Panacinar (Panlobular) Emphysema

• Uniform destruction from respiratory bronchiole all the way to the terminal alveoli - the entire acinus is enlarged
• Distribution: Lower lobes predominate; anterior margins
• Cause: Strongly associated with α1-antitrypsin (A1AT) deficiency; exacerbated by smoking
• ZZ homozygotes for the Pi locus on chromosome 14 have very low A1AT serum levels; >80% of ZZ individuals develop symptomatic panacinar emphysema

(C) Distal Acinar (Paraseptal) Emphysema

• Proximal acinus is normal; distal portion is primarily involved
• Located near the pleura, along lobular connective tissue septa, near areas of scarring or atelectasis
• More severe in upper lung halves
• Creates enlarged airspaces up to >2 cm and bullae
• Clinical relevance: Classically presents as spontaneous pneumothorax in young adults

(D) Irregular (Paracicatricial) Emphysema

• Acinus is irregularly involved, almost always associated with scarring
• Clinically insignificant in most cases

---

4. Pathogenesis

(i) Toxic Injury & Inflammation

• Inhaled cigarette smoke damages respiratory epithelium and recruits inflammatory cells
• Resident macrophages and epithelial cells release mediators: LTB4, IL-8, TNF, and others
• This triggers chemotaxis of neutrophils and macrophages to the lung
• Chronic inflammation leads to accumulation of T and B lymphocytes

(ii) Protease-Antiprotease Imbalance (the central mechanism)

• Neutrophils and macrophages release elastase and other proteases that degrade connective tissue, particularly elastin in alveolar walls
• Normally, α1-antitrypsin (A1AT) inhibits these elastases
• In emphysema, there is a relative deficiency of antiproteases - either acquired (in smokers) or genetic (A1AT deficiency)
• Loss of elastin = loss of radial traction on respiratory bronchioles → bronchiolar collapse on expiration → functional airflow obstruction without mechanical blockage

(iii) Oxidative Stress

• Tobacco smoke and inflammatory cells generate reactive oxygen species (ROS)
• ROS cause direct tissue damage and worsen the antiprotease deficit (oxidants inactivate A1AT)
• The NRF2 pathway (encoded by NFE2L2) normally counteracts oxidants; genetic variants in this pathway increase susceptibility to smoking-related lung disease
• Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 636

---

5. Morphology (Gross & Histology)

• Advanced emphysema: voluminous, pale lungs that overlap the heart anteriorly and flatten the diaphragm
• Panacinar: pale, very voluminous
• Centriacinar: deeper pink, upper 2/3 more severely affected; less voluminous until late
• Apical blebs and bullae (spaces >1 cm) may be present, especially in irregular emphysema

• Abnormally large alveoli separated by thin septa
• Destruction of alveolar walls without fibrosis (key distinguishing feature)
• Decreased capillary bed (loss of alveolar capillaries)
• Pores of Kohn enlarged - septa appear "floating" or protrude club-shaped into air spaces
• Terminal/respiratory bronchioles deformed due to loss of anchoring septa
• Bronchiolar inflammation and submucosal fibrosis in advanced disease

---

6. Pathophysiology of Airflow Obstruction

1. Loss of elastic recoil - destruction of elastin in alveolar walls removes the radial traction that normally holds small airways open
2. Bronchiolar collapse during expiration - without radial traction support, respiratory bronchioles collapse on expiration → air trapping and hyperinflation
3. Loss of capillary bed → reduced diffusion capacity → hypoxemia (late)
4. Pulmonary hypertension - from hypoxia-induced vascular spasm + loss of capillary surface area → right heart strain → cor pulmonale

---

7. Clinical Features

Symptoms

• Dyspnea is the first and most prominent symptom; begins insidiously and is steadily progressive
• In chronic bronchitis-predominant COPD: cough and wheezing may precede dyspnea
• Weight loss can be prominent (increased work of breathing, reduced appetite)

Classic Physical Examination - the "Pink Puffer"

• Barrel chest (increased anterior-posterior diameter due to hyperinflation)
• Pursed-lip breathing during expiration (auto-PEEP to prevent airway collapse)
• Sitting hunched forward (tripod position)
• Prolonged expiration
• Pink skin (relatively preserved oxygenation until late stages)
• Hyperresonant chest on percussion
• Reduced breath sounds, quiet chest

Pulmonary Function Tests (PFTs)

Blood Gases

• Early/mild disease: relatively normal ABGs (hyperventilation compensates)
• Late/severe disease: hypoxemia, eventually hypercapnia and respiratory acidosis
• Until very late, many emphysema patients maintain adequate gas exchange due to increased respiratory drive

Imaging

• CXR: Hyperinflated lungs, flattened diaphragm (the classic sign), increased retrosternal air space, hyperlucency, small heart
• CT chest: Gold standard for assessing type and extent of emphysema; can show bullae, cysts, and distribution (upper vs. lower lobe predilection)

---

8. Complications

---

9. Other Forms (Non-COPD Emphysema)

---

10. Management Overview

---

11. Quick Summary Table

---

• Robbins & Kumar Basic Pathology (10th ed.), pp. 447-451
• Robbins, Cotran & Kumar Pathologic Basis of Disease (10th ed.), pp. 634-639
• Fishman's Pulmonary Diseases and Disorders